Background & Purpose
Global events have exposed weaknesses in EU supply chains, prompting the European Commission to propose new rules to secure access to critical medicines across member states.
Proposals & Debate
The Commission's proposal aims to strengthen the supply of critical medicines by changing legislation and streamlining processes. However, the Swedish parliament examined whether this respects the principle that decisions should be taken as close to citizens as possible.
The Decision
Sweden formally objects to parts of the EU proposal by sending a reasoned opinion to EU leaders, arguing that the Union is interfering too much in national decision-making.
Does this affect you?
- National authorities: Retain their independent power to handle building permits and environmental reviews without direct EU interference.
- Healthcare providers: Affected by long-term EU efforts to secure the supply chains for critical medicines.
In Practice
- The Swedish parliament sends a formal warning, known as a reasoned opinion, to the presidents of the European Parliament, the Council, and the Commission.
- Sweden insists that national authorities must retain full control over local planning and building processes.
- Environmental review regulations for strategic projects must remain a purely national matter according to the Swedish stance.